Myeloma cell culture in transferrin-free low iron medium
AssigneeMedImmune, LLC
InventorsMatthew David Osborne, Jonathan H. Dempsey
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.
Claims17
A method for the in vitro culture of a myeloma cell line, said method comprising:
- (a) inoculating a culture medium with the myeloma cell line, said medium being capable of supporting the growth of said myeloma cell line and comprising iron at concentrations in the medium of from 0.064 mg/L to 1.6 mg/L, wherein said medium does not contain any of a transferrin, a lipophilic chelator, a synthetic nitrogen-containing chelator and a lipophilic synthetic nitrogen-containing chelator;
- and
- (b) growing of the inoculated culture medium under appropriate conditions and using agitated suspension culture, and
- wherein the source of iron is a soluble iron compound selected from the group consisting of ferric ammonium citrate, ferric ammonium oxalate, ferric ammonium fumarate, ferric ammonium malate and ferric ammonium succinate.
A method for the in vitro culture of a myeloma cell line, the method comprising:
- (a) inoculating a culture medium with the myeloma cell line, said medium being capable of supporting the growth of said myeloma cell line and comprising ferric ammonium citrate at a concentration in the medium of from 0.4 mg/L to 10 mg/L, wherein said medium does not contain any of a transferrin, a lipophilic chelator, a synthetic nitrogen-containing chelator and a lipophilic synthetic nitrogen-containing chelator;
- and
- (b) growing of the inoculated culture medium under appropriate conditions and using agitated suspension culture.
A process for obtaining a mammalian cell product comprising culturing a myeloma cell capable of producing said product under agitated suspension culture and in a culture medium capable of supporting the growth of said myeloma cell line, said medium comprising iron at concentrations in the medium of from 0.064 mg/L to 1.6 mg/L, or ferric ammonium citrate at a concentration in the medium of from about 0.4 mg/L to about 10 mg/L, wherein said medium does not contain any of a transferrin, a lipophilic chelator, a synthetic nitrogen-containing chelator and a lipophilic synthetic;
- nitrogen-containing chelator;
- and recovering said mammalian cell product, and
- wherein the source of iron is a soluble iron compound selected from the group consisting of ferric ammonium citrate, ferric ammonium oxalate, ferric ammonium fumarate, ferric ammonium malate and ferric ammonium succinate.
Dependencies are inferred from the claim text.